REQUEST A DEMO
Total
USD $0.00
Search more companies

DSD Pharma s.r.o. (Slovakia)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: DSD Pharma s.r.o. Profile Updated: April 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

DSD Pharma s.r.o. is an enterprise based in Slovakia. Its main office is in Banska Bystrica. The enterprise operates in the All Other Professional, Scientific, and Technical Services industry. The enterprise was incorporated on May 15, 2009. 2 - 3 (2023) employees currently work for DSD Pharma s.r.o.. From the latest financial highlights, DSD Pharma s.r.o. reported a net sales revenue increase of 33.12% in 2023. Over the same period, its total assets grew by 87.23%. The net profit margin of DSD Pharma s.r.o. decreased by 0.39% in 2023.

Headquarters
Janka Krala 5
Banska Bystrica; Banskobystricky; Postal Code: 97401

Contact Details: Purchase the DSD Pharma s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the DSD Pharma s.r.o. report to view the information.
Outstanding Shares:
Purchase the DSD Pharma s.r.o. report to view the information.
Registered Capital:
Purchase the DSD Pharma s.r.o. report to view the information.
Incorporation Date:
May 15, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after DSD Pharma s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
33.12%
Total operating revenue
33.09%
Operating profit (EBIT)
4.08%
EBITDA
6.87%
Net Profit (Loss) for the Period
-0.37%
Total assets
87.23%
Total equity
35.67%
Operating Profit Margin (ROS)
-0.44%
Net Profit Margin
-0.39%
Return on Equity (ROE)
-9.51%
Debt to Equity Ratio
-0.03%
Quick Ratio
-0.13%
Cash Ratio
0.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?